SAREPTA THERAPEUTICS INC (1SRPT.MI) Stock Price & Overview
BIT:1SRPT • US8036071004
Current stock price
The current stock price of 1SRPT.MI is 18.755 EUR. Today 1SRPT.MI is up by 27.24%. In the past month the price increased by 12.54%.
1SRPT.MI Key Statistics
- Market Cap
- 1.969B
- P/E
- N/A
- Fwd P/E
- 7.21
- EPS (TTM)
- -5.73
- Dividend Yield
- N/A
1SRPT.MI Stock Performance
1SRPT.MI Stock Chart
1SRPT.MI Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to 1SRPT.MI.
1SRPT.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to 1SRPT.MI. 1SRPT.MI may be in some trouble as it scores bad on both profitability and health.
1SRPT.MI Earnings
On February 25, 2026 1SRPT.MI reported an EPS of -3.93 and a revenue of 442.93M. The company missed EPS expectations (-213.05% surprise) and beat revenue expectations (10.8% surprise).
1SRPT.MI Forecast & Estimates
33 analysts have analysed 1SRPT.MI and the average price target is 26.4 EUR. This implies a price increase of 40.78% is expected in the next year compared to the current price of 18.755.
For the next year, analysts expect an EPS growth of 145.42% and a revenue growth -19.12% for 1SRPT.MI
1SRPT.MI Groups
Sector & Classification
1SRPT.MI Financial Highlights
Over the last trailing twelve months 1SRPT.MI reported a non-GAAP Earnings per Share(EPS) of -5.73. The EPS decreased by -391.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -21.3% | ||
| ROE | -62.55% | ||
| Debt/Equity | 0.73 |
1SRPT.MI Ownership
1SRPT.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ARGX | ARGENX SE | 26.92 | 39.964B | ||
| 1AE | ARGENX SE | 26.88 | 39.927B | ||
| 22UA | BIONTECH SE-ADR | N/A | 18.671B | ||
| ABVX | ABIVAX SA | N/A | 8.065B | ||
| 2X1 | ABIVAX SA | N/A | 8.05B | ||
| GLPG | GALAPAGOS NV | N/A | 1.709B | ||
| GXE | GALAPAGOS NV | N/A | 1.707B | ||
| NANO | NANOBIOTIX | N/A | 1.401B | ||
| 6IV | INVENTIVA SA | N/A | 1.001B | ||
| IVA | INVENTIVA SA | N/A | 949.989M | ||
| PHIL | PHILOGEN SPA | 17.77 | 660.824M | ||
| GNFT | GENFIT | 846.08 | 431.525M | ||
| FYB | FORMYCON AG | N/A | 335.023M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1SRPT.MI
Company Profile
The company is headquartered in Cambridge, Massachusetts and currently employs 835 full-time employees.
Company Info
IPO: 1997-06-04
SAREPTA THERAPEUTICS INC
215 First Street, Suite 415
Cambridge MASSACHUSETTS US
Employees: 835
Phone: 16172744000
SAREPTA THERAPEUTICS INC / 1SRPT.MI FAQ
What does 1SRPT do?
The company is headquartered in Cambridge, Massachusetts and currently employs 835 full-time employees.
Can you provide the latest stock price for SAREPTA THERAPEUTICS INC?
The current stock price of 1SRPT.MI is 18.755 EUR. The price increased by 27.24% in the last trading session.
Does 1SRPT stock pay dividends?
1SRPT.MI does not pay a dividend.
How is the ChartMill rating for SAREPTA THERAPEUTICS INC?
1SRPT.MI has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the next earnings date for 1SRPT stock?
SAREPTA THERAPEUTICS INC (1SRPT.MI) will report earnings on 2026-05-04, after the market close.
Can you provide the ownership details for 1SRPT stock?
You can find the ownership structure of SAREPTA THERAPEUTICS INC (1SRPT.MI) on the Ownership tab.